228 related articles for article (PubMed ID: 25402950)
21. Toll-like receptor 3 mediates expression of clusterin/apolipoprotein J in vascular smooth muscle cells stimulated with RNA released from necrotic cells.
Baiersdörfer M; Schwarz M; Seehafer K; Lehmann C; Heit A; Wagner H; Kirschning CJ; Koch-Brandt C
Exp Cell Res; 2010 Dec; 316(20):3489-500. PubMed ID: 20692254
[TBL] [Abstract][Full Text] [Related]
22. Secretory clusterin inhibits osteoclastogenesis by attenuating M-CSF-dependent osteoclast precursor cell proliferation.
Choi B; Kang SS; Kang SW; Min BH; Lee EJ; Song DH; Kim SM; Song Y; Yoon SY; Chang EJ
Biochem Biophys Res Commun; 2014 Jul; 450(1):105-9. PubMed ID: 24866235
[TBL] [Abstract][Full Text] [Related]
23. Secreted Clusterin protein inhibits osteoblast differentiation of bone marrow mesenchymal stem cells by suppressing ERK1/2 signaling pathway.
Abdallah BM; Alzahrani AM; Kassem M
Bone; 2018 May; 110():221-229. PubMed ID: 29476977
[TBL] [Abstract][Full Text] [Related]
24. Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress.
Trougakos IP; So A; Jansen B; Gleave ME; Gonos ES
Cancer Res; 2004 Mar; 64(5):1834-42. PubMed ID: 14996747
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic role of meloxicam targeting secretory clusterin-mediated invasion in hepatocellular carcinoma cells.
Zhong J; Yu X; Dong X; Lu H; Zhou W; Li L; Li Z; Sun P; Shi X
Oncol Lett; 2018 May; 15(5):7191-7199. PubMed ID: 29731881
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways.
Balantinou E; Trougakos IP; Chondrogianni N; Margaritis LH; Gonos ES
Free Radic Biol Med; 2009 May; 46(9):1267-74. PubMed ID: 19353783
[TBL] [Abstract][Full Text] [Related]
27. Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer.
Zoubeidi A; Chi K; Gleave M
Clin Cancer Res; 2010 Feb; 16(4):1088-93. PubMed ID: 20145158
[TBL] [Abstract][Full Text] [Related]
28. Chapter 2: Clusterin (CLU): From one gene and two transcripts to many proteins.
Rizzi F; Coletta M; Bettuzzi S
Adv Cancer Res; 2009; 104():9-23. PubMed ID: 19878770
[TBL] [Abstract][Full Text] [Related]
29. Expression and purification of chaperone-active recombinant clusterin.
Dabbs RA; Wilson MR
PLoS One; 2014; 9(1):e86989. PubMed ID: 24466307
[TBL] [Abstract][Full Text] [Related]
30. ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence.
Luo X; Suzuki M; Ghandhi SA; Amundson SA; Boothman DA
PLoS One; 2014; 9(6):e99983. PubMed ID: 24937130
[TBL] [Abstract][Full Text] [Related]
31. Effects of glycosylation on the structure and function of the extracellular chaperone clusterin.
Stewart EM; Aquilina JA; Easterbrook-Smith SB; Murphy-Durland D; Jacobsen C; Moestrup S; Wilson MR
Biochemistry; 2007 Feb; 46(5):1412-22. PubMed ID: 17260971
[TBL] [Abstract][Full Text] [Related]
32. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex.
Trougakos IP; Lourda M; Antonelou MH; Kletsas D; Gorgoulis VG; Papassideri IS; Zou Y; Margaritis LH; Boothman DA; Gonos ES
Clin Cancer Res; 2009 Jan; 15(1):48-59. PubMed ID: 19118032
[TBL] [Abstract][Full Text] [Related]
33. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
[TBL] [Abstract][Full Text] [Related]
34. Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.
Deb M; Sengupta D; Rath SK; Kar S; Parbin S; Shilpi A; Pradhan N; Bhutia SK; Roy S; Patra SK
Biochim Biophys Acta; 2015 Aug; 1852(8):1630-45. PubMed ID: 25917404
[TBL] [Abstract][Full Text] [Related]
35. CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype.
Mazzarelli P; Pucci S; Spagnoli LG
Adv Cancer Res; 2009; 105():45-61. PubMed ID: 19879422
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of clusterin/apolipoprotein J in lactacystin-treated SH-SY5Y cells.
Carreras I; Garrett-Young R; Ullman MD; Eisenhauer PB; Fine RE; Wells JM; Conn KJ
J Neurosci Res; 2005 Feb; 79(4):495-502. PubMed ID: 15635600
[TBL] [Abstract][Full Text] [Related]
37. Modulation of clusterin isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cells.
Orlandi A; Pucci S; Ciucci A; Pichiorri F; Ferlosio A; Spagnoli LG
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):348-53. PubMed ID: 15591223
[TBL] [Abstract][Full Text] [Related]
38. The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process.
Lenzi C; Ramazzina I; Russo I; Filippini A; Bettuzzi S; Rizzi F
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003328
[TBL] [Abstract][Full Text] [Related]
39. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer.
Wei L; Xue T; Wang J; Chen B; Lei Y; Huang Y; Wang H; Xin X
Int J Cancer; 2009 Aug; 125(4):791-806. PubMed ID: 19391138
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals.
Zhong J; Yu X; Dong X; Lu H; Zhou W; Li L; Li Z; Sun P; Shi X
Int J Mol Med; 2018 May; 41(5):2893-2900. PubMed ID: 29436591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
